Postoperative complications (including wound infection) (16‐24 months) · women with posterior vaginal wall prolapse
Biological graft probably leads to higher postoperative complications (including wound infection) (16‐24 months) compared with native tissue repair (moderate certainty).
1 finding from 1 review
Operating time · women with posterior vaginal wall prolapse
1 finding from 1 review
Awareness of prolapse · women with posterior vaginal wall prolapse
Transanal repair showed no clear difference in awareness of prolapse (subjective failure) (12‐25 months) compared with transvaginal repair (low certainty).
1 finding from 1 review
Recurrent posterior vaginal wall prolapse (objective failure) (12‐25 months) · women with posterior vaginal wall prolapse
Transanal repair probably leads to higher recurrent posterior vaginal wall prolapse (objective failure) (12‐25… compared with transvaginal repair (moderate certainty).
1 finding from 1 review
Postoperative obstructed defecation (6‐25 months) · women with posterior vaginal wall prolapse
Transanal repair showed no clear difference in postoperative obstructed defecation (6‐25 months) compared with transvaginal repair (low certainty).
1 finding from 1 review
Postoperative dyspareunia (12‐25 months) · women with posterior vaginal wall prolapse
Transanal repair showed no clear difference in postoperative dyspareunia (12‐25 months) compared with transvaginal repair (low certainty).
1 finding from 1 review
Postoperative complications (6‐25 months) · women with posterior vaginal wall prolapse
Transanal repair showed no clear difference in postoperative complications (6‐25 months) compared with transvaginal repair (low certainty).
1 finding from 1 review
Operating time · women with posterior vaginal wall prolapse
1 finding from 1 review
Outcomes ( · women with posterior vaginal wall prolapse
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Uterine volume (cm³) · women with uterine fibroids
1 finding from 1 review
Intraoperative blood loss (mL) · women with uterine fibroids
3 findings from 1 review
Blood transfusion · women with uterine fibroids
GnRHa treatment showed no clear difference in blood transfusions compared with no pretreatment or placebo before myomectomy (operative and… (low certainty).
3 findings from 1 review
Overall postoperative morbidity · women with uterine fibroids
GnRHa treatment showed no clear difference in postoperative morbidity compared with no pretreatment or placebo before myomectomy (operative and… (low certainty).
3 findings from 1 review
Fibroid volume (cm³) · women with uterine fibroids
1 finding from 1 review
Uterine volume (cm³) · women with uterine fibroids
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Fibroid volume (cm³) · women with uterine fibroids
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Haemoglobin (g/dL) · women with uterine fibroids
1 finding from 1 review
Preoperative bleeding: (PBAC < 75) ulipristal acetate 5 mg · women with uterine fibroids
SPRM may leads to higher preoperative bleeding: (PBAC < 75) ulipristal acetate 5 mg compared with placebo (low certainty).
1 finding from 1 review
Preoperative bleeding: Reduction in bleeding to PBAC < 75 ulipristal acetate 10 mg · women with uterine fibroids
SPRM may leads to higher preoperative bleeding: Reduction in menstrual bleeding (PBAC < 75)… compared with placebo (low certainty).
1 finding from 1 review
Preoperative bleeding: Change in menstrual blood loss from baseline to end of treatment · women with uterine fibroids
1 finding from 1 review